ACARE
•    1. Zuraw BL. Diagnosis and management of hereditary angioedema: an American approach. Transfus Apher Sci. 2003; 29(3): 239-245. PubMedWeb of Science®Google Scholar
•    346Zuraw BL, Banerji A, Bernstein JA, et al. US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency. J 
•    Banerji A, Bas M, Bernstein JA, et al. Expert perspectives on hereditary angioedema: key areas for advancements in care across the patient journey. Allergy Rhinol (Providence). 2016; 7(3): 172-181.
Banerji A, Busse P, Christiansen SC, et al. Current state of hereditary angioedema management: a patient survey. Allergy Asthma Proc. 2015; 36(3): 213-217.
View
PubMedWeb of Science®Google Scholar
•    349Boccon-Gibod I. Hereditary angioedema: treatment and educational therapeutic program. Presse Med. 2015; 44(1): 78-88.
View
PubMedWeb of Science®Google Scholar
•    350Nasr IH, Manson AL, Al Wahshi HA, Longhurst HJ. Optimizing hereditary angioedema management through tailored treatment approaches. Expert Rev Clin Immunol. 2016; 12(1): 19-31.
View
CASPubMedWeb of Science®Google Scholar
•    351Aygoren-Pursun E, Bork K. Hereditary angioedema. Der Internist. 2019; 60(9): 987-995.
View
PubMedWeb of Science®Google Scholar
•    352Aygoren-Pursun E, Martinez-Saguer I, Rusicke E, Klingebiel T, Kreuz W. On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experience. Allergy Asthma Clin Immunol. 2010; 6(1): 21.
View
PubMedGoogle Scholar
•    353Gill P, Betschel SD. The clinical evaluation of angioedema. Immunol Allergy Clin North Am. 2017; 37(3): 449-466.
View
PubMedWeb of Science®Google Scholar
•    354Manson AL, Price A, Dempster J, et al. In pursuit of excellence: an integrated care pathway for C1 inhibitor deficiency. Clin Exp Immunol. 2013; 173(1): 1-7.
View
CASPubMedWeb of Science®Google Scholar
•    355Krack AT, Bernstein JA, Ruddy RM. Recognition, evaluation, and management of pediatric hereditary angioedema. Pediatr Emerg Care. 2021; 37(4): 218-223.
View
PubMedWeb of Science®Google Scholar
•    356Maurer M, Aberer W, Agondi R, et al. Definition, aims, and implementation of GA(2) LEN/HAEi Angioedema Centers of Reference and Excellence. Allergy. 2020; 75(8): 2115-2123.
View
PubMedWeb of Science®Google Scholar
•    357Serpa FS, Mansour E, Aun MV, et al. Hereditary angioedema: how to approach it at the emergency department? Einstein (Sao Paulo). 2021; 19: eRW5498.
View
PubMedWeb of Science®Google Scholar
•    358Pines JM, Poarch K, Hughes S. Recognition and differential diagnosis of hereditary angioedema in the emergency department. J Emerg Med. 2021; 60(1): 35-43.
View
PubMedWeb of Science®Google Scholar
•    359Hahn J, Bock B, Muth CM, et al. The ulm emergency algorithm for the acute treatment of drug-induced, bradykinin-mediated angioedema. Med Klin Intensivmed Notfmed. 2019; 114(8): 708-716.
View
CASPubMedWeb of Science®Google Scholar
•    360Long BJ, Koyfman A, Gottlieb M. Evaluation and management of angioedema in the emergency department. West J Emerg Med. 2019; 20(4): 587-600.
View
PubMedWeb of Science®Google Scholar
•    361Cicardi M, Craig TJ, Martinez-Saguer I, Hebert J, Longhurst HJ. Review of recent guidelines and consensus statements on hereditary angioedema therapy with focus on self-administration. Int Arch Allergy Immunol. 2013; 161(Suppl 1): 3-9.
View
PubMedWeb of Science®Google Scholar
•    362Muhlberg H, Ettl N, Magerl M. An analysis of the teaching of intravenous self-administration in patients with hereditary angio-oedema. Clin Exp Dermatol. 2016; 41(4): 366-371.
View
CASPubMedWeb of Science®Google Scholar
•    363Zanichelli A, Azin GM, Cristina F, Vacchini R, Caballero T. Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert(R)) in patients with hereditary angioedema: the SABHA study. Orphanet J Rare Dis. 2018; 13(1): 51.
View
PubMedWeb of Science®Google Scholar
•    364Aberer W, Maurer M, Reshef A, et al. Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema. Allergy. 2014; 69(3): 305-314.
View
CASPubMedWeb of Science®Google Scholar
•    365Kreuz W, Rusicke E, Martinez-Saguer I, Aygoren-Pursun E, Heller C, Klingebiel T. Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema. Transfusion. 2012; 52(1): 100-107.
View
CASPubMedWeb of Science®Google Scholar
•    366Bernstein JA, Riedl M, Zacek L, Shapiro RS. Facilitating home-based treatment of hereditary angioedema. Allergy Asthma Proc. 2015; 36(2): 92-99.
View
PubMedWeb of Science®Google Scholar
•    367Bygum A. Hereditary angioedema - consequences of a new treatment paradigm in Denmark. Acta Derm Venereol. 2014; 94(4): 436-441.
View
CASPubMedWeb of Science®Google Scholar
•    368Li HH. Self-administered C1 esterase inhibitor concentrates for the management of hereditary angioedema: usability and patient acceptance. Patient Prefer Adherence. 2016; 10: 1727-1737.
View
PubMedWeb of Science®Google Scholar
•    369Tourangeau LM, Castaldo AJ, Davis DK, Koziol J, Christiansen SC, Zuraw BL. Safety and efficacy of physician-supervised self-managed c1 inhibitor replacement therapy. Int Arch Allergy Immunol. 2012; 157(4): 417-424.
View
CASPubMedWeb of Science®Google Scholar
•    370Tuong LA, Olivieri K, Craig TJ. Barriers to self-administered therapy for hereditary angioedema. Allergy Asthma Proc. 2014; 35(3): 250-254.
View
PubMedWeb of Science®Google Scholar
•    371Symons C, Rossi O, Magerl M, Andritschke K. Practical approach to self-administration of intravenous C1-INH concentrate: a nursing perspective. Int Arch Allergy Immunol. 2013; 161(Suppl 1): 17-20.
View
PubMedWeb of Science®Google Scholar
•    372Wilson DA, Bork K, Shea EP, Rentz AM, Blaustein MB, Pullman WE. Economic costs associated with acute attacks and long-term management of hereditary angioedema. Ann Allergy Asthma Immunol. 2010; 104(4): 314-320.
View
PubMedWeb of Science®Google Scholar
•    373Zilberberg MD, Jacobsen T, Tillotson G. The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007. Allergy Asthma Proc. 2010; 31(6): 511-519.
View
PubMedWeb of Science®Google Scholar
•    374Abdel-Karim O, Dizdarevic A, Bygum A. Hereditary angioedema: children should be considered for training in self-administration. Pediatr Dermatol. 2014; 31(6): e132-e135.
View
PubMedWeb of Science®Google Scholar
•    375Craig T. Triggers and short-term prophylaxis in patients with hereditary angioedema. Allergy Asthma Proc. 2020; 41(Suppl 1): S30-S34.
View
CASPubMedWeb of Science®Google Scholar
•    376Steiner UC, Kolliker L, Weber-Chrysochoou C, et al. Food as a trigger for abdominal angioedema attacks in patients with hereditary angioedema. Orphanet J Rare Dis. 2018; 13(1): 90.
View
PubMedWeb of Science®Google Scholar
•    377Teranishi R, Makino Y, Amano E, Shibuya H, Okada T. Perioperative management of a patient with hereditary angioedema: a case report. Masui. 2015; 64(4): 441-443.
PubMedGoogle Scholar
•    378Visy B, Fust G, Bygum A, et al. Helicobacter pylori infection as a triggering factor of attacks in patients with hereditary angioedema. Helicobacter. 2007; 12(3): 251-257.
View
PubMedWeb of Science®Google Scholar
•    379Zotter Z, Veszeli N, Kohalmi KV, et al. Bacteriuria increases the risk of edematous attacks in hereditary angioedema with C1-inhibitor deficiency. Allergy. 2016; 71(12): 1791-1793.
View
CASPubMedWeb of Science®Google Scholar
•    380Belbezier A, Arnaud M, Boccon-Gibod I, et al. COVID-19 as a trigger of acute attacks in people with hereditary angioedema. Clin Exp Allergy. 2021; 51(7): 947-950.
View
CASPubMedWeb of Science®Google Scholar
•    381Can Bostan O, Tuncay G, Damadoglu E, Karakaya G, Kalyoncu AF. Effect of COVID-19 on hereditary angioedema activity and quality of life. Allergy Asthma Proc. 2021; 42(5): 403-408.
View
PubMedWeb of Science®Google Scholar
•    382Grumach AS, Goudouris E, Dortas Junior S, et al. COVID-19 affecting hereditary angioedema patients with and without C1 inhibitor deficiency. J Allergy Clin Immunol Pract. 2021; 9(1): 508-510.
View
CASPubMedWeb of Science®Google Scholar
•    383Mete Gokmen N, Kuman Tuncel O, Bogatekin G, et al. Psychiatric and clinical characteristics of hereditary angioedema patients who experienced attacks during COVID-19. J Investig Allergol Clin Immunol. 2021; 31(4): 356-357.
View
CASPubMedWeb of Science®Google Scholar
•    384Fijen LM, Levi M, Cohn DM. COVID-19 vaccination and the risk of swellings in patients with hereditary angioedema. J Allergy Clin Immunol Pract. 2021; 9(11): 4156-4158.
View
CASPubMedWeb of Science®Google Scholar
•    385Araujo-Simoes J, Boanova AGP, Constantino-Silva RN, et al. The challenges in the follow-up and treatment of brazilian children with hereditary angioedema. Int Arch Allergy Immunol. 2021; 182(7): 585-591.
View
CASPubMedWeb of Science®Google Scholar
•    386Johnston DT, Smith RC. Hereditary angioedema: Special considerations in children. Allergy Asthma Proc. 2020; 41(Suppl 1): S43-S46.
View
PubMedWeb of Science®Google Scholar
•    387Valle SOR, Alonso MLO, Tortora RP, Abe AT, Levy SAP, Dortas SD Jr. Hereditary angioedema: Screening of first-degree blood relatives and earlier diagnosis. Allergy Asthma Proc. 2019; 40(4): 279-281.
View
CASPubMedWeb of Science®Google Scholar